DocMorris AG Stock price

Equities

ROSE

CH0042615283

Drug Retailers

Real-time Estimate Cboe Europe 08:32:34 2024-03-28 am EDT 5-day change 1st Jan Change
90.42 CHF +5.88% Intraday chart for DocMorris AG +13.51% +22.51%
Sales 2024 * 1.19B 1.32B Sales 2025 * 1.65B 1.82B Capitalization 1B 1.11B
Net income 2024 * -76M -83.91M Net income 2025 * -10M -11.04M EV / Sales 2024 * 1.03 x
Net Debt 2024 * 225M 249M Net Debt 2025 * 251M 277M EV / Sales 2025 * 0.76 x
P/E ratio 2024 *
-13 x
P/E ratio 2025 *
-82.3 x
Employees 1,453
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.44%
1 week+14.95%
Current month+10.57%
1 month+9.98%
3 months+22.98%
6 months+84.18%
Current year+24.07%
More quotes
1 week
79.80
Extreme 79.8
91.60
1 month
70.50
Extreme 70.5
91.60
Current year
68.80
Extreme 68.8
101.60
1 year
28.52
Extreme 28.52
101.60
3 years
23.02
Extreme 23.02
431.00
5 years
23.02
Extreme 23.02
514.00
10 years
23.02
Extreme 23.02
514.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 14-12-31
Founder 66 93-04-05
Director of Finance/CFO 49 00-12-31
Members of the board TitleAgeSince
Director/Board Member 69 10-03-31
Director/Board Member 51 19-05-22
Founder 66 93-04-05
More insiders
Date Price Change Volume
24-03-28 90.55 +6.03% 112 586
24-03-27 85.4 +3.96% 93,078
24-03-26 82.15 -5.57% 88,663
24-03-25 87 +2.47% 94,554
24-03-22 84.9 +6.66% 216,961

Delayed Quote Swiss Exchange, March 28, 2024 at 06:15 am EDT

More quotes
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
85.4 CHF
Average target price
88.91 CHF
Spread / Average Target
+4.11%
Consensus
  1. Stock
  2. Equities
  3. Stock DocMorris AG - Swiss Exchange